Mr. Morrison has served as a member of GBT’s board of directors since January 2016. He had a 35-year career in public accounting, serving public and private companies in the life sciences sector. Mr. Morrison was a partner at Ernst & Young LLP and served as its U.S. life sciences leader. He has worked on hundreds of public and private financings, including more than 40 IPOs and 100 follow-on offerings. He is considered an expert in the M&A arena. Mr. Morrison currently serves on the boards of directors of Corvus Pharmaceuticals, Ideaya Biosciences, Vera Therapeutics, and Zai Labs. He has served on numerous life sciences industry boards, including the Biotechnology Innovation Organization (BIO) ECS Board, the Bay Area Bioscience Center Board (now California Life Sciences), the California Life Sciences Foundation, and the Biotechnology Institute. Mr. Morrison holds a B.S. in accounting and finance from the University of California, Berkeley. He is a certified public accountant (inactive).